V

Vericel® Corporation Tech Stack

Cell therapy manufacturer for orthopedic and burn care

Biotechnology Research Cambridge, Massachusetts 201–500 employees Founded 1989 Public Company

Vericel manufactures autologous cell therapies and specialty biologics for sports medicine and severe burn repair. The company is actively scaling sales and manufacturing operations (9 open sales roles, 7 manufacturing) while adopting manufacturing execution systems (MES) and lab information systems (LIMS) — a shift toward tighter production control as they expand MACI adoption across hospital networks. Current friction centers on hospital procurement complexity and clinician engagement, suggesting a transition from R&D-led to commercialization-led operations.

Tech Stack 10 technologies

Core StackVeeva Microsoft Office Outlook Word Excel LIMS PowerPoint Microsoft Project Visio

AdoptingMES LIMS

What Vericel® Corporation Is Building

◆Challenges

Increasing maci adoption
Complex hospital procurement processes
Increasing hcp engagement needs
Reducing audit observations
Open payments compliance
Data privacy protection
Vendor management
Sae susar reporting
Signal management
Uninterrupted supply of materials

▲Active Projects

Maci adoption in assigned territory
Clinical education for maci implantation
Real-time surgical support
Maci adoption strategy
Clinical education program
Training on prescription product promotion
Advising product development on promotional considerations
Scalable compliance program
Hcp engagement needs assessment
Monitoring plan execution

Hiring Activity

Accelerating30 roles · 15 in 30d

Department

Sales

9

Manufacturing

7

Ops

4

Engineering

1

Healthcare

1

HR

1

Legal

1

Operations

1

Seniority

Junior

8

Manager

7

Mid

5

Senior

5

Director

3

Company intelligence

Find more companies like Vericel® Corporation by tech stack, pain points and active projects

Get started free

About Vericel® Corporation

Vericel is a Cambridge-based public biotech company marketing two autologous cell therapy products and one specialty biologic in the United States. The company serves orthopedic surgeons and burn care teams, with revenue-generating products already in use. Current operational focus spans clinical education for surgical implantation, real-time surgical support, and hospital procurement strategy — indicating mature commercialization rather than early-stage development. The company maintains clinical trial infrastructure, regulatory compliance programs, and supply-chain operations typical of established specialty biologic manufacturers.

HeadquartersCambridge, Massachusetts

Company Size201–500 employees

Founded1989

Hiring MarketsUnited States

Frequently Asked Questions

What is Vericel Corporation's main product?

Vericel markets two autologous cell therapy products and one specialty biologic product in the United States, focused on sports medicine and severe burn care repair.